Business Wire

Strong Revenue Growth in 2019 and Promising Outlook

Share

Kalray (Paris:ALKAL) (Euronext Growth Paris : ALKAL), a pioneer in processors for new intelligent systems, reviews its business in the second half of 2019 (from July 1 to December 31, 2019) and looks back over the highlights of the period.

Eric Baissus, President of Kalray’s Executive Board, commented as follows: “2019 was a pivotal year for Kalray marked by the achievement of a number of key milestones. First of all, we finished developing our 3rd generation Coolidge™ processor and presented it for the first time in early January at CES. Mass production is scheduled to start second semester of 2020. Furthermore, strategic agreements were signed with top-tier players including NXP, Wistron, 2CRSI and Intron Technology, which will boost our credibility and accelerate time to market for Coolidge™.

Our target of achieving revenues of €100 million by 2022 have been confirmed by the initial performances of Coolidge™, the industry enthusiasm which we were able to measure at CES and the numerous negotiations underway. The initial signs of a growth upswing already visible in H2 2019 are expected to intensify in 2020. Given this outlook, we are continuing our structuring initiatives, particularly through hiring, and we keep reviewing a number of potential partnerships geared to support our development.

The recent market concentration and discussions with our partners demonstrate how crucial acceleration and artificial intelligence technologies are for the future, and how they occupy a core position in a market with huge potential. They confirm the relevance of our positioning and technology and confirm our ambitions of becoming a leading supplier on this market.”

SUCCESSFUL INITIAL DEMONSTRATIONS OF COOLIDGE™ ALONGSIDE NXP AT CES 2020

Kalray gave the first technical demonstration of its Coolidge™ third-generation MPPA® (Massively Parallel Processor Array) processor at the CES 2020 international trade show in Las Vegas held from January 7-10, 2020.

Just a few weeks after receiving the first samples, Kalray gave the first public demonstration of its Coolidge™ processor in conjunction with NXP Semiconductors, a leading global semiconductor manufacturer and year-long partner of Kalray, as part of an AI application. As announced earlier, the strategic partnership with NXP is designed to produce a secure and reliable solution for autonomous vehicles. The partnership will combine the computing power and reliability of Kalray’s processors with the decision-making power and automotive know-how of NXP processors within NXP’s Bluebox on-board autonomous driving platform.

So far, the performances achieved with Coolidge™ are fully in line with Kalray’s expectations. This 3rd generation processor offers major improvements in the use of MPPA® technology: performances multiplied 25-fold1 compared to the 2nd generation MPPA®, extension of artificial intelligence capabilities, easier programming, high-speed interfaces, etc.

Coolidge™ will play a key role in Kalray’s plans on both the data center market, by meeting the growing need for data center acceleration, and the automotive market, by allowing the integration of multiple critical functionalities on a single processor while supporting ultra high-level performances.

Coolidge™ samples are due to be generally available from April 2020 before the planned launch of mass production in H2 2020. Kalray has already received initial product development requests from a number of customers and prospects in both the data center and automotive sectors.

STRATEGIC AGREEMENTS WITH TOP-TIER PLAYERS

In 2019, Kalray continued to seal strategic partnerships with top-tier players, thereby enhancing its visibility and once again confirming the quality of its technical expertise and appropriateness of its positioning.

In October, Kalray announced a new distribution partnership with leading automotive electronics distributor Intron Technology for the Chinese market, in order to accelerate its access to this strategic market for Coolidge™.

The Company also announced a collaboration with 2CRSi, a leading French designer-manufacturer of high-performance servers. 2CRSi is using Kalray’s programmable acceleration boards to build an offering of easily configurable servers designed to meet the growing demand for flexibility, modularity and diversity of application.

REVENUES UP 63% IN 2019

Kalray posted H2 2019 revenues of €810,000, up 78% from €455,000 in H1 2019, in line with management forecasts. This performance brought full-year revenues to €1,265,000, up 63% from €775,000 in 2018. These revenues are generated from sales of boards, development stations and licenses as well as evaluation, development and service contracts with customers for the evaluation and qualification phases.

15 NEW HIRES IN 2019 AND NEW INDEPENDENT SUPERVISORY BOARD MEMBER APPOINTED

As announced, in order to support its expected increase in business, Kalray has continued to invest, particularly in the area of recruitment. Accordingly, the Company hired 15 new employees in 2019, 9 in H1 and 6 in H2, mainly in the R&D and sales departments. Total headcount at 2019 year-end stood at 81.

Kalray also recently appointed Erwan Menard, currently Director of Infrastructure and Applications Modernization Solutions at Google Cloud, as an independent Supervisory Board member. Based in California, Erwan will bring Kalray his expertise in storage and network infrastructure technology for cloud computing and data centers, and will help drive the Company’s ambitions on these markets.

€15.7 MILLION CASH AND CASH EQUIVALENTS AS OF DECEMBER 31, 2019

As of December 31, 2019, cash and cash equivalents stood at €15.7 million (versus €23.3 million as of June 30, 2019), after investments expenditures in H2 on the Coolidge™ launch (including $4 million on the tape-out mask) offset by an improvement in working capital (research tax credit). In line with management forecasts, FY 2019 cash outflow was similar to that of 2018.

This cash position will allow Kalray to pursue its tech roadmap and sales roll-out program in 2020 and thereafter.

Furthermore, on the recommendation of the compensation committee and under the authorization granted by the Supervisory Board on January 16, 2020, the Executive Board, on its meeting on January 20, 2020, exercised the authorization granted by the shareholders’ general meeting on May 29, 2019 (20th resolution) to issue and allot 134,299 bonus shares to Executive Board members and Kalray Group employees out of which 105,599 shares have been allotted in exchange for waiving the right to exercise 105,599 warrants (BSPCE) previously allotted to employees & founders. This authorization is designed to encourage key personnel to stay with the Company while limiting the dilutive impact for shareholders. The Supervisory Board also approved the allotment and vesting terms applicable to the bonus shares, which shall be vested in tranches of one-third, the first tranche one year after the date of allotment by the Executive Board, subject to a further lock-in period of one year from vesting, the second tranche two years after allotment and the third tranche three years after allotment by the Executive Board.

SALES RAMP-UP EXPECTED FROM H2 2020

Mass sale of Coolidge™-based acceleration boards remains Kalray’s main target for 2020. A period of strong sales ramp-up is expected to kick in during the second half.

In light of the multiple negotiations and commercial evaluations currently underway, Kalray is maintaining its 2022 revenue target of €100 million.

Futhermore, Kalray constantly evaluates opportunities to support its long term development. These opportunities can involve discussions with industrial or financial partners.

Next publication:

Monday April 20, 2020 (after market close): 2019 annual results

ABOUT KALRAY

Kalray (Euronext Growth Paris - FR0010722819 - ALKAL) is the pioneer in processors for new intelligent systems. A genuine technological breakthrough, “intelligent” processors are able to intelligently analyze a vast quantity of data on the fly and to make decisions and interact in real time with the outside world. These intelligent processors will be largely deployed in fast-growing sectors such as new-generation networks (intelligent data centers) and autonomous vehicles, as well as in healthcare equipment, drones and robots. Kalray’s offering spans both processors and global solutions (electronic boards and software). Created in 2008 as a spin-off of CEA (“Commissariat à l’Énergie Atomique”, the French Alternative Energies and Atomic Energy Commission), Kalray addresses a broad spectrum of customers including server manufacturers, intelligent system integrators and consumer product manufacturers such as car makers. Read more at: www.kalrayinc.com

1 25 TOPS (Tera Operations Per Second) performance for Coolidge versus 1 TOPS for previous generation Bostan

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

INVESTOR CONTACTS
Eric BAISSUS
contactinvestisseurs@kalray.eu
Tel. +33 (0)4 76 18 90 71

ACTUS finance & communication
Caroline LESAGE
kalray@actus.fr
+ 33 1 53 67 36 79

MEDIA CONTACTS
Loic HAMON
communication@kalray.eu
Tel. +33 (0)4 76 18 90 71

ACTUS finance & communication
Serena BONI
sboni@actus.fr
Tel. +33 (0)4 72 18 04 92

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 18:03:00 CEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 14:30:00 CEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 14:00:00 CEST | Press release

The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin

HiddenA line styled icon from Orion Icon Library.Eye